{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:15:05Z","timestamp":1777590905566,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115737-2 \u2013 COMBACTE-MAGNET"],"award-info":[{"award-number":["115737-2 \u2013 COMBACTE-MAGNET"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jinf.2019.10.021","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T17:59:29Z","timestamp":1572717569000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome"],"prefix":"10.1016","volume":"80","author":[{"given":"Wafa","family":"Ibn Saied","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sybille","family":"Merceron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Schwebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alban","family":"Le Monnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johana","family":"Oziel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mait\u00e9","family":"Garrouste-Orgeas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Marcotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Ruckly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Souweine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lila","family":"Bouadma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"de Montmollin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Mourvillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Papazian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shidasp","family":"Siami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"B\u00e9dos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Francois","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2019.10.021_bib0001","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jinf.2012.01.001","article-title":"Stenotrophomonas maltophilia\u2013the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study","volume":"64","author":"V","year":"2012","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jinf.2019.10.021_bib0002","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/cc5063","article-title":"Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome","volume":"10","author":"Nseir","year":"2006","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.jinf.2019.10.021_bib0003","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.021_bib0004","first-page":"1","article-title":"Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors","volume":"13","author":"Trifonova","year":"2018","journal-title":"Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2019.10.021_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10096-007-0279-3","article-title":"Antimicrobial therapy for Stenotrophomonas maltophilia infections","volume":"26","author":"Nicodemo","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.021_bib0006","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2019.10.021_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14787210.2014.864553","article-title":"New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen","volume":"12","author":"Brooke","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"7","key":"10.1016\/j.jinf.2019.10.021_bib0008","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jinf.2019.10.021_bib0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/00365548.2013.871644","article-title":"Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii","volume":"46","author":"Soubirou","year":"2014","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2019.10.021_bib0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10096-008-0518-2","article-title":"Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia","volume":"27","author":"Paez","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2019.10.021_bib0011","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00003246-200202000-00017","article-title":"Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole study","volume":"30","author":"Montravers","year":"2002","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.jinf.2019.10.021_bib0012","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.201102-0331OC","article-title":"Early-onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis","volume":"184","author":"Perbet","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jinf.2019.10.021_bib0013","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1086\/340707","article-title":"Attributable mortality of Stenotrophomonas maltophilia bacteremia","volume":"34","author":"Senol","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2019.10.021_bib0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1371\/journal.pone.0037375","article-title":"Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome","volume":"7","author":"Samonis","year":"2012","journal-title":"PLoS One"},{"issue":"893","key":"10.1016\/j.jinf.2019.10.021_bib0015","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang","year":"2015","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.jinf.2019.10.021_bib0016","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/23744235.2016.1185534","article-title":"Stenotrophomonas maltophilia ventilator-associated pneumonia. A retrospective matched case-control study","volume":"48","author":"Scholte","year":"2016","journal-title":"Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2019.10.021_bib0017","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/341022","article-title":"Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients","volume":"35","author":"Hanes","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2019.10.021_bib0018","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1086\/648455","article-title":"Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia","volume":"30","author":"Tseng","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.jinf.2019.10.021_bib0019","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhin.2013.09.007","article-title":"Outbreak of Stenotrophomonas maltophilia on an intensive care unit","volume":"85","author":"Guyot","year":"2013","journal-title":"J Hosp Infect"},{"issue":"4","key":"10.1016\/j.jinf.2019.10.021_bib0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012","volume":"43","author":"Sader","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jinf.2019.10.021_bib0021","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/ajrccm.157.2.9705064","article-title":"Ventilator-associated pneumonia caused by potentially drug-resistant bacteria","volume":"157","author":"Trouillet","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jinf.2019.10.021_bib0022","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cncr.21846","article-title":"Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients","volume":"106","author":"Boktour","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jinf.2019.10.021_bib0023","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/fmb.09.84","article-title":"Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature","volume":"4","author":"Falagas","year":"2009","journal-title":"Future Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2019.10.021_bib0024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","article-title":"EUCAST expert rules in antimicrobial susceptibility testing","volume":"19","author":"Leclercq","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.jinf.2019.10.021_bib0025","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.01774-09","article-title":"Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S","volume":"54","author":"Farrell","year":"2010","journal-title":"maltophilia infections. Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.jinf.2019.10.021_bib0026","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/AAC.49.9.3980-3981.2005","article-title":"Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia","volume":"49","author":"Metan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2019.10.021_bib0027","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1592\/phco.31.4.338","article-title":"Clinical and microbiologic outcomes in trauma patients treated for Stenotrophomonas maltophilia ventilator-associated pneumonia","volume":"31","author":"Czosnowski","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jinf.2019.10.021_bib0028","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/cid\/ciy371","article-title":"The Association between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: A Prospective Study","volume":"27","author":"Zak-Doron","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2019.10.021_bib0029","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/CCM.0000000000003305","article-title":"The Impact of Early Adequate Treatment on Extubation and Discharge Alive of Patients With Pseudomonas aeruginosa-Related Ventilator-Associated Pneumonia","volume":"46","author":"Sommer","year":"2018","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.jinf.2019.10.021_bib0030","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10096-017-3050-4","article-title":"Co-infection of Pseudomonas aeruginosa and Stenotrophomonas maltophilia in hospitalised pneumonia patients has a synergic and significant impact on clinical outcomes","volume":"36","author":"Yin","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2019.10.021_bib0031","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jinf.2008.02.012","article-title":"Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study","volume":"56","author":"Nseir","year":"2008","journal-title":"J Infect"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:29:26Z","timestamp":1759008566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319303354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0163445319303354"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.10.021","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}